Results 191 to 200 of about 7,864,333 (249)

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Evaluation of the Importance of Stopping Elderly Accidents, Deaths, and Injuries (STEADI)-Based Factors in Wearable Fall Risk Assessment: Secondary Data Analysis. [PDF]

JMIR Mhealth Uhealth
Ghoreishi N, Ansah S, Lu J, Lu W, Moon S, Delgado F, Chen D.   +6 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice. [PDF]

BMJ Oncol
Reijnen C, Pijnenborg JMA, Hoskin P, Mcwilliam A, Lucas PJF, Hommersom A, Kwisthout J, Choudhury A.   +7 more
europepmc   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

Using tDCS to Investigate Fear Extinction in a Large Population of Healthy Volunteers

Brain Stimulation
Michael Nitsche, Yuanbo Ma, Giorgi Batzikadse, Fujia Jiao, Fatemeh Yavari   +4 more
doaj   +1 more source

Constructs Influencing Patient Perceptions of Use of AI in Medical Imaging Analysis: Systematic Review. [PDF]

Interact J Med Res
Kuppanda PM, Janda M, Caffery LJ.
europepmc   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Investigation of Risk Factors Related to Stroke in the Bangladeshi Population: A Cross-Sectional Study. [PDF]

Health Sci Rep
Murad MA, Kuddus A, Hasan SA, Ashik MIH, Ghosh S, Sultana S, Priya SR, Kawsar MAB, Uddin R, Biswas M.   +9 more
europepmc   +1 more source